Deals Of Consequence That Evolved Out Of JPM

Rob Wright, chief editor of Life Science Leader, conducted an executive virtual roundtable (EVR) with In this video segment, three biopharma executives share examples of significant biopharmaceutical industry deals that have evolved out of JPM. This is part of a larger executive virtual roundtable (EVR) conducted by Rob Wright, chief editor of Life Science Leader, that included Terry-Ann Burrell, CFO, Beam Therapeutics; Hunter Smith, CFO, Rhythm Pharmaceuticals; and Jim Woody, Ph.D., CEO, 180 Life Sciences (view full video here). The topic for this EVR is the 39th Annual J.P. Morgan Healthcare Conference being 100% virtual in 2021, and how that’s impacting preparations.